New center aims to accelerate research into biomarkers of neurodegenerative diseases

A new center established at Washington University School of Medicine in St. Louis aims to accelerate research into biomarkers of neurodegenerative conditions such as Huntington's and Parkinson's diseases, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and the so-called tauopathies, a group that includes Alzheimer's disease along with rarer diseases such as frontotemporal dementia, corticobasal syndrome and progressive supranuclear palsy.

Related Keywords

Barbara Burton ,Steven Susan Lipstein ,Gary Werths ,David Holtzman ,Kanta Horie ,Reubenm Morriss ,Emily Henderson ,David Payne ,Randallj Bateman ,Nicolas Barth ,Richard Frimel ,School Of Medicine ,Neuroscience Research Building ,Institute Of Health ,Washington University School Of Medicine ,Tracy Family Stable Isotope Labeling Quantitation Center ,Foundation For Barnes ,Washington University School ,Neurodegenerative Biology ,Tracy Family ,Joanne Knight Distinguished Professor ,Susan Lipstein ,Willman Family ,Diagnostics ,Lzheimer 39s Disease ,Amyotrophic Lateral Sclerosis ,Flood ,Rain ,Children ,Dementia ,Iagnostic ,Frontotemporal Dementia ,Mass Spectrometry ,Medicine ,Multiple Sclerosis ,Neurodegenerative Diseases ,Eurology ,Progressive Supranuclear Palsy ,Protein ,Research ,Clerosis ,Spectrometer ,Pectrometry ,Yndrome ,